Knowledge Graphs
ナレッジグラフ
Bring Knowledge Graphs to Life through Real-World Scientific Applications
現実世界の科学アプリケーションにナレッジグラフを応用
2025年4月2日 米国東部標準時(EDT)
4月2日(水)
Registration and Morning Coffee8:00 am
Organizer's Remarks9:00 am
BUILDING AND LEVERAGING FOUNDATIONAL KNOWLEDGE GRAPHS FOR BIOMEDICAL RESEARCH
バイオメディカル研究向けナレッジグラフの構築と活用
Human Reference Atlas Knowledge Graph: Construction and Applications
Katy Börner, PhD, Victor H. Yngve Distinguished Professor of Engineering and Information Science, Intelligent Systems Engineering, Indiana University
Experts from 20 consortia are collaborating to build the Human Reference Atlas (HRA), which aims to map the 37 trillion cells in the healthy human body. The HRA Knowledge Graph contains over 6 million nodes and 57 million
edges, enabling complex data queries through the HuBMAP portal, HRA Organ Gallery, and other tools. This presentation will explore how HuBMAP, SenNet, and GTEx data are integrated into the HRA to support precision
health and medicine at scale. Learn more at https://humanatlas.io and https://humanatlas.io/api.
A Graph Database with Billions of Nodes and Edges Linking Mouse and Human Genetics
Matthew Gerring, MEng, Senior Manager, Computational Sciences, The Jackson Laboratory
Over the last three years we have been working on a vast array of data and linking it into a graph database. Using techniques including streaming, intermediate SQL databases and bulk import we have built a database
which links mouse and human genes and can be used in a wide range of scientific research. This talk will detail how we did that computationally and show how to use the database.
Advancing Medical QA: A Knowledge Graph Agent for Complex, Multi-Strategy Reasoning
Xiaorui Su, PhD, Harvard Medical School
Biomedical knowledge is uniquely complex and structured, requiring distinct reasoning strategies compared to other scientific disciplines. This diversity calls for flexible approaches that accommodate multiple reasoning
strategies while leveraging in-domain knowledge. We introduce KGARevion, a knowledge graph (KG) based agent designed to address the complexity of knowledge-intensive medical queries. Upon receiving a query, KGARevion
generates relevant triplets using the LLM knowledge base. These triplets are then verified against a grounded KG to filter out erroneous information and ensure that only accurate, relevant data contribute to the final
answer.
Networking Coffee Break10:55 am
SAGE: Scientific Discovery through AI-Infused Knowledge Graphs to Enrich Disease Understanding
Miguel R. Goncalves, PhD, Associate Director, Oncology R&D, AstraZeneca
SAGE is an easy-to-use platform built to facilitate knowledge generation from multiomics and clinical data. It is based on a rich dataset from which a dedicated Knowledge Graph (KG) was built. Additionally, we trained an LLM to communicate with the KG, including a chatbot functionality to enable wide access to data-generated insights, all without the risk of hallucination. Learn how this platform facilitates scientific discovery for disease understanding.
Enhancing Drug Manufacturing with a Batch Genealogy Knowledge Graph
John M. Apathy, Chief Solutions Officer, Life Sciences, XponentL Data, Inc.
?Batch Genealogy is a core data product at the heart of the Product Development, Manufacturing, and Supply Chain domains in any Biopharmaceutical company. Batch Xplorer is a vital resource to serve end-to-end manufacturing
batch genealogy data needs such as product developability, product market compliance, and quality investigations. Leveraging AWS Neptune RDF graph database technology, the solution provides a comprehensive set of
functionalities for data ingestion, profiling, transformation, navigation, retrieval, and analysis. The underlying solution architecture implemented was built integrating internal and external batch data in an
RDF Graph Database (AWS Neptune) and with a user interface built in AWS Amplify.
Transition to Lunch12:05 pm
Harnessing AI to Identify Causal Relationships and Enhance Research and Scientific Validation in Pharma
Peter Doerr, Director, Presales, metaphacts
This talk discusses how AI methods can help find gaps between curated knowledge in knowledge graphs and unstructured knowledge in scientific texts. We provide examples of how databases like OpenTargets can be enriched by using AI to identify causal relationships in scientific documents. With Knowledge Graph technology, these relationships are used to augment existing databases, allowing users to compare, spot gaps and, crucially, find the relevant literature to ensure scientific validation.
Luncheon Presentation (Sponsorship Opportunity Available) or Enjoy Lunch on Your Own12:45 pm
Session Break1:15 pm
ADVANCING BIOMEDICAL INSIGHTS: KNOWLEDGE GRAPHS, AI/ML, AND GENERATIVE FRAMEWORKS IN RESEARCH AND DRUG DISCOVERY
バイオメディカルインサイトの推進:研究・創薬におけるナレッジグラフ、AI/ML、生成フレームワーク
Knowledge Graphs: Bridging the Clinic and Drug Discovery
Michael Liebman, PhD, Managing Director, IPQ Analytics, LLC
An accurate understanding of disease is the cornerstone of bridging the clinic and drug discovery. This requires accounting for the real-world complexities of patients, diseases, and clinical practice. This presentation
highlights a unique application of knowledge graphs to uncover critical gaps and resolve conflicts in data. Focused on women’s health, it explores the interaction between physiologic development, disease risk, and
clinical presentation to advance therapeutic discovery.
Acknowledgment: This work includes contributions from Sasha Rieders, Data Scientist, IPQ Analytics LLC
Integrating AI/ML Solutions with Cutting-Edge Biology to Identify New Condensate Targets and Revolutionary Medicine
Avinash Patel, PhD, Senior Director, Head Exploratory Sciences, Dewpoint Therapeutics GmbH
Biomolecular condensates regulate key biological processes, and their dysfunction, or condensatopathies, drives disease. These are novel therapeutic targets for drug discovery. Dewpoint’s AI-powered platform uses graph-based target identification, multi-omics data, and deep learning models to optimize condensate-modifying drugs (c-mods). This approach prioritizes c-mods for diseases like colorectal cancer, addressing key dysfunctions. Dewpoint’s platform supports oncology and neurodegeneration programs, developing innovative small-molecule therapies for high unmet needs.
Integrating LLMs, Ontologies, and Graph Structures: A Unified Framework for Advanced Data Insights
Ray Lukas, Principal Emerging Technologies Engineer, The MITRE Corporation, MITRE Labs
This talk introduces a cutting-edge framework that integrates large language models (LLMs), ontologies, and graph structures to unify disparate datasets for biomedical research. This unified platform enhances the ability
to derive advanced insights through natural language queries, removing the need for expertise in native query languages. Positioned as a bridge between foundational graph technologies and generative AI, this framework
offers transformative potential for life sciences applications, accelerating discovery and innovation.
Networking Refreshment Break2:50 pm
Sponsored Presentation (Opportunity Available)3:10 pm
Pre-Introducing Knowledge Graphs and Large Language Models: Dangerous Predictions about the Next Token
Brian Martin, Chief AI Product Owner, BTS; Head of AI, R&D Information Research; Senior Research Fellow, AbbVie, Inc.
Explore the dynamic intersection of knowledge graphs and large language models in this forward-looking session. This talk delves into the emerging possibilities and risks as semantic data integrates with generative AI,
offering ‘dangerous predictions’ about the next token. Join us to examine how these technologies could reshape scientific discovery, data interpretation, and innovation across life sciences and beyond.
Refreshment Break & Transition to Plenary Keynote4:30 pm
From Bytes to Breakthroughs: Generative AI Driving the Future of Life Sciences and Healthcare
Subha Madhaven, Vice President and Head, AI/ML, Quantitative and Digital Sciences, Global Metrics and Data Management, Pfizer Inc.
Generative AI has the potential to transform life sciences and deliver unprecedented insights, automation, and efficiency. But is it? This keynote panel brings together leaders from biopharma, healthcare, and emerging tech who are leveraging AI to advance drug discovery, diagnostics, and patient care. Panelists will share their own case studies and real-world applications and discuss how they’ve tackled challenges—both technical and cultural. Look beyond the hype curve to see how this technology is really being used now and where the next opportunities lie.
Welcome Reception in the Exhibit Hall with Poster Viewing (Sponsorship Opportunity Available)6:10 pm
The Bio-IT Kickoff Reception is a reunion—reconnect with friends, explore cutting-edge research, and celebrate innovation! Enjoy poster presentations, networking, and vote for the Best of Show and Poster awards.
Close of Day7:25 pm
* 不測の事態により、事前の予告なしにプログラムが変更される場合があります。